1 December 2024 false No description of principal activity Taxfiler 2024.6 08226415 business:PrivateLimitedCompanyLtd 2024-12-01 2025-11-30 08226415 2024-11-30 08226415 2024-12-01 2025-11-30 08226415 business:AuditExempt-NoAccountantsReport 2024-12-01 2025-11-30 08226415 business:FilletedAccounts 2024-12-01 2025-11-30 08226415 2025-11-30 08226415 business:Director1 2024-12-01 2025-11-30 08226415 business:RegisteredOffice 2024-12-01 2025-11-30 08226415 2024-11-30 08226415 core:WithinOneYear 2025-11-30 08226415 core:WithinOneYear 2024-11-30 08226415 core:ShareCapital core:PreviouslyStatedAmount 2025-11-30 08226415 core:ShareCapital core:PreviouslyStatedAmount 2024-11-30 08226415 core:RetainedEarningsAccumulatedLosses core:PreviouslyStatedAmount 2025-11-30 08226415 core:RetainedEarningsAccumulatedLosses core:PreviouslyStatedAmount 2024-11-30 08226415 core:PreviouslyStatedAmount 2025-11-30 08226415 core:PreviouslyStatedAmount 2024-11-30 08226415 business:SmallEntities 2024-12-01 2025-11-30 08226415 countries:EnglandWales 2024-12-01 2025-11-30 08226415 core:PlantMachinery 2024-12-01 2025-11-30 08226415 core:ComputerEquipment 2024-12-01 2025-11-30 08226415 core:PlantMachinery 2024-11-30 08226415 core:ComputerEquipment 2024-11-30 08226415 core:PlantMachinery 2025-11-30 08226415 core:ComputerEquipment 2025-11-30 08226415 core:AfterOneYear 2025-11-30 08226415 core:AfterOneYear 2024-11-30 08226415 2023-12-01 2024-11-30 iso4217:GBP xbrli:pure
Company Registration No. 08226415 (England and Wales)
Alpharma Limited Unaudited accounts for the year ended 30 November 2025
Alpharma Limited Unaudited accounts Contents
Page
Company information
3
Statement of financial position
4
Notes to the accounts
5
- 2 -
Alpharma Limited Company Information for the year ended 30 November 2025
Director
M Issat
Company Number
08226415 (England and Wales)
Registered Office
195-197 OTLEY ROAD BRADFORD WEST YORKSHIRE BD3 0JF
- 3 -
Alpharma Limited Statement of financial position as at 30 November 2025
2025
2024
Notes
£
£
Fixed assets
Tangible assets
4
2,157
2,696
Current assets
Debtors
5
42,838
42,454
Cash at bank and in hand
739
1,133
43,577
43,587
Creditors: amounts falling due within one year
6
(49,028)
(41,855)
Net current (liabilities)/assets
(5,451)
1,732
Net (liabilities)/assets
(3,294)
4,428
Capital and reserves
Called up share capital
150
150
Profit and loss account
(3,444)
4,278
Shareholders' funds
(3,294)
4,428
For the year ending 30 November 2025 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies. The members have not required the company to obtain an audit in accordance with section 476 of the Companies Act 2006.
The director acknowledges his responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts.
These accounts have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies' regime and in accordance with the provisions of FRS 102 Section 1A - Small Entities. The profit and loss account has not been delivered to the Registrar of Companies.
The financial statements were approved by the Board and authorised for issue on 29 May 2026 and were signed on its behalf by
M Issat Director Company Registration No. 08226415
- 4 -
Alpharma Limited Notes to the Accounts for the year ended 30 November 2025
1
Statutory information
Alpharma Limited is a private company, limited by shares, registered in England and Wales, registration number 08226415. The registered office is 195-197 OTLEY ROAD, BRADFORD, WEST YORKSHIRE, BD3 0JF.
2
Compliance with accounting standards
The accounts have been prepared in accordance with the provisions of FRS 102 Section 1A Small Entities. There were no material departures from that standard.
3
Accounting policies
The principal accounting policies adopted in the preparation of the financial statements are set out below and have remained unchanged from the previous year, and also have been consistently applied within the same accounts.
Basis of preparation
The accounts have been prepared under the historical cost convention as modified by the revaluation of certain fixed assets.
Presentation currency
The accounts are presented in £ sterling.
Tangible fixed assets and depreciation
Tangible assets are included at cost less depreciation and impairment. Depreciation has been provided at the following rates in order to write off the assets over their estimated useful lives:
Plant & machinery
20% reducing balance
Computer equipment
50% straight line
4
Tangible fixed assets
Plant & machinery
Computer equipment
Total
£
£
£
Cost or valuation
At cost
At cost
At 1 December 2024
8,201
11,226
19,427
At 30 November 2025
8,201
11,226
19,427
Depreciation
At 1 December 2024
5,505
11,226
16,731
Charge for the year
539
-
539
At 30 November 2025
6,044
11,226
17,270
Net book value
At 30 November 2025
2,157
-
2,157
At 30 November 2024
2,696
-
2,696
- 5 -
Alpharma Limited Notes to the Accounts for the year ended 30 November 2025
5
Debtors
2025
2024
£
£
Amounts falling due within one year
VAT
573
-
Other debtors
42,265
42,265
42,838
42,265
Amounts falling due after more than one year
Other debtors
-
189
6
Creditors: amounts falling due within one year
2025
2024
£
£
VAT
-
543
Taxes and social security
-
4,227
Other creditors
36,200
35,000
Loans from directors
11,168
-
Accruals
1,660
2,085
49,028
41,855
7
Average number of employees
During the year the average number of employees was 3 (2024: 3).
- 6 -